Stock Stories - Bamboo Works - China stock insights for global investors

Stories About 1093.HK

CSPC has unveiled a record licensing deal with AstraZeneca

Big deal, bigger doubts: CSPC slides after $18.5 billion pact

2026-02-12

CSPC delivered lower nine-month revenues and profits

CSPC feels the pain from sweeping cuts in drug prices

2025-11-27

CSPC Pharma teases big bucks deals after earnings miss

CSPC Pharma teases big bucks deals after earnings miss

2025-06-12

Earnings blow for CSPC Pharma

Earnings blow for CSPC Pharma as the state drives a hard bargain

2025-03-06

BRIEF: CSPC Pharma profit dips on falling drug revenue

2024-11-01

CSPC develops, produces and sells its own innovative drugs. Its growth has been sluggish over the past three years due to a slowdown for its finished drug business.

FAST NEWS: CSPC Pharma’s urticaria drug approved in China

2024-10-09

Liu Yongjun’s experience in the commercialization of innovative drugs and his connections with multinational pharmaceutical companies are urgently needed for CSPC Pharmaceutical’s ongoing transformation.

CSPC Pharma taps R&D superstar in quest for new breakout drugs

2024-09-19

CSPC Pharma weighs up diet drug for bigger bottom line

CSPC Pharma weighs up diet drug for bigger bottom line

2024-06-05

CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough

2023-03-29

Discover hidden China stock gems in our weekly newsletter

Follow us

Subscribe to Our Free eNewsletter

Check out our content with some of our syndication partners